I Was Shocked at Who Is Now Running Berkshire Hathaway's $308 Billion Stock Portfolio

Greg Abel, as CEO, now has ultimate responsibility for Berkshire Hathaway's $308B public equity portfolio and $373B in cash and short-term Treasuries; Ted Weschler manages roughly 6% of investments, implying Abel oversees the remaining ~94%. Abel has no prior public-equity track record and has emphasized detailed oversight of operating businesses, suggesting Berkshire may favor whole-company acquisitions (Alleghany in 2022; Pilot Travel Centers and Cove Point in 2023; OxyChem in 2025) in insurance, energy and industrials over large new public-stock bets like the 2016 Apple position. For portfolio managers, the likely consequence is a strategic tilt toward M&A and operating assets rather than aggressive equity trading, increasing execution and integration risk while potentially reducing opportunistic stock-picking alpha.

Analysis

Consolidation of capital-allocation authority into a single CEO increases the probability that Berkshire will favor lumpy, strategic whole-company deals over opportunistic public-equity purchases. Mechanically, that shifts demand from continuous, patient buying in large-cap liquid names to concentrated bids in a smaller set of insurance/energy/industrial sellers — expect volatility dispersion to widen between individually targeted sellers and broad-cap indices over the next 6–24 months.

Second-order beneficiaries are advisors, M&A bankers, and private sellers in Berkshire's operational wheelhouse; sellers can rationally price a strategic premium knowing a single decision-maker can greenlight large deals faster. Conversely, the marginal support that a patient large buyer provided to big-cap, low-turnover stocks will weaken — not a liquidity crisis, but a structural reduction in buyer-of-last-resort flows that raises downside convexity for names that historically benefited from that support.

Tail risks center on execution: a CEO without a deep public-equity trading record can mis-time entries into equities or overpay for conglomerates, compressing ROIC and compressing Berkshire’s NAV multiple over 12–36 months. Key catalysts to watch are (1) disclosure of new large cash deployments or takeover filings, (2) shifts in buy/sell patterns in 13F and options market making large-net sales visible, and (3) any public comments that re-characterize the firm from hybrid investor-operator to primarily acquirer of whole businesses.

Key Decisions for Investors

• Tactical hedge: Buy BRKB 12–18 month put spreads sized at 0.5–1% of portfolio notional to protect vs 10–20% headline downside. Rationale: limited-cost protection for increased downside convexity; reward profile = 3–8x premium if governance/strategy missteps compress valuation.
• Relative-value pair: Long AAPL and NVDA (equal dollar) vs short BRKB (30–40% of tech notional) over 6–12 months. Rationale: tech secular growth likely outperforms a conglomerate deploying capital into slower-return acquisitions; risk = broad tech drawdown, hedge with index puts if volatility rises.
• Event-driven longs: Accumulate concentrated positions in pure-play insurance/energy targets (example: CB, OXY) on 12–24 month horizon or buy LEAP calls to capture takeover premium. Rationale: higher probability of strategic approach raises bid risk for sellers; downside = regulatory deal break or benign competitive auctions eroding premium.
• Liquidity/volatility strategy: If 13F/option flow shows sustained reduction in large-cap buying from the firm, sell volatility on mega-cap names using calendar spreads (short front-month, long 6–9 month) to capture elevated near-term realized vol. Rationale: short-term spikes create premium; risk = persistent realized vol outstrips implied, cap losses quickly.